Helen Kim

Ms. Kim served as Executive Vice President of Business Development at Kite Pharma where she led all business and corporate development initiatives, successfully selling Kite to Gilead in 2017 for $11.9B. Prior to Kite, she served as Chief Business Officer and later Strategic Advisor at NGM Biopharmaceuticals.

2019 © NKMax America | Terms of Use | Privacy Policy